Is zegalogue for low sugar?

Is Zegalogue suitable for managing low blood sugar?

Zegalogue, also known as dasiglucagon, is an emergency glucagon-like peptide-1 (GLP-1) receptor antagonist used to treat severe hypoglycemia, or low blood sugar, in adults and children with diabetes [1]. It is not intended for routine management of hypoglycemia.

How does Zegalogue work?

Zegalogue works by mimicking the effects of GLP-1, a hormone released by the intestines in response to food. GLP-1 helps raise blood glucose levels by increasing glucose production in the liver, reducing glucose use in the muscles, and enhancing insulin sensitivity [1].

Why is Zegalogue not a long-term solution for low blood sugar?

While Zegalogue is effective for treating acute episodes of severe hypoglycemia, its use is limited to emergency situations due to its potential side effects and the risk of allergic reactions [1]. It is also a powder that requires mixing with liquid before administration, which may not be suitable for everyday use.

What are the differences between Zegalogue and other GLP-1 analogues?

Other GLP-1 analogues, such as glucagon, are used to treat hypoglycemia and have a longer shelf life and easier administration compared to Zegalogue [2]. Additionally, GLP-1 analogues have a more sustained release profile, allowing for longer duration of action.

Who makes Zegalogue?

Zegalogue is developed and marketed by Zealand Pharma A/S [3].

When does the patent for Zegalogue expire?

The patent for Zegalogue expires in 2038, giving Zealand Pharma A/S exclusive marketing rights for the product [4].

Sources:

[1] U.S. Food and Drug Administration. (2022). Zegalogue Prescribing Information.

[2] Glucagon [Package Insert]. Eli Lilly and Company.

[3] Zealand Pharma A/S. (n.d.). About Us.

[4] DrugPatentWatch. (n.d.). Zegalogue Patent Expiration Date.